help button home button Endocrine Society JCEM JCEM Call for Nominations for EIC
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Article
Right arrow Submit a related Letter to the Editor
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Rayfield, E. J.
Right arrow Articles by Horwitz, D. L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Rayfield, E. J.
Right arrow Articles by Horwitz, D. L.

Journal of Clinical Endocrinology & Metabolism, Vol 43, 1307-1311, Copyright © 1976 by Endocrine Society

ARTICLES

Nonautonomous function of a pancreatic insulinoma

EJ Rayfield, M Pulini, A Golub, AH Rubenstein and DL Horwitz

A 56-year-old woman with symptoms of weakness, visual blurring, and sweating underwent diagnostic studies to evaluate the etiology of her hypoglycemia. Fasting hypoglycemia was never documented; in diagnostic studies performed during her two hospitalizations and several outpatient glucose tolerance tests, the lowest fasting plasma glucose recorded was 56 mg/dl. The patient displayed exaggerated plasma insulin responses following oral glucose (peak response: 447 muU/ml at 30 min) and following 1 gm of iv tolbutamide (peak response: 719 muU/ml at 5 min) with symptomatic profound hypoglyceria during both tests. Basal per cent proinsulin was elevated at 49% (normal range 5-22%). Throughout a 72 h fast, values for plasma glucose, insulin, and glucose/insulin ratios were all within the normal range. During the infusion of exogenous insulin (0.1 U/kg for 60 min) serum C-peptide reactivity suppressed to less than 1.3 ng/ml when the plasma glucose fell below 40 mg/dl representing normal suppression. At surgery, a pancreatic beta cell adenoma was found and removed. This patient represents the uncommon circumstances in which stimulation tests with tolbutamide and glucose were more helpful in establishing a preoperative diagnosis than were the suppression tests.


This article has been cited by other articles:


Home page
 Eur J EndocrinolHome page
D Vezzosi, A Bennet, J Fauvel, and P Caron
Insulin, C-peptide and proinsulin for the biochemical diagnosis of hypoglycaemia related to endogenous hyperinsulinism
Eur. J. Endocrinol., July 1, 2007; 157(1): 75 - 83.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
B. Hirshberg, A. Livi, D. L. Bartlett, S. K. Libutti, H. R. Alexander, J. L. Doppman, M. C. Skarulis, and P. Gorden
Forty-Eight-Hour Fast: The Diagnostic Test for Insulinoma
J. Clin. Endocrinol. Metab., September 1, 2000; 85(9): 3222 - 3226.
[Abstract] [Full Text]

Home page
 J. Clin. Endocrinol. Metab.Home page
F. J. Service, N. Natt, G. B. Thompson, C. S. Grant, J. A. van Heerden, J. C. Andrews, E. Lorenz, A. Terzic, and R. V. Lloyd
Noninsulinoma Pancreatogenous Hypoglycemia: A Novel Syndrome of Hyperinsulinemic Hypoglycemia in Adults Independent of Mutations in Kir6.2 and SUR1 Genes
J. Clin. Endocrinol. Metab., May 1, 1999; 84(5): 1582 - 1589.
[Abstract] [Full Text]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 1976 by The Endocrine Society